Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib versus Bendamustine plus Rituximab (BR) in Patients with Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

#2021
#BLOOD

PMU Autor*innen
Richard Greil, Alan Cohen

Alle Autor*innen
CS Tam, K. Giannopoulos, W. Jurczak, M. Simkovic, M. Shadman, A. Osterborg, L. Laurenti, P. Walker, S. Opat, H. Chan, H. Ciepluch, Richard Greil, M. Tani, M. Trneny, DM Brander, IW Flinn, S. Grosicki, E. Verner, JR Brown, BS Kahl, P. Ghia, T. Tian, C. Marimpietri, JC Paik, Alan Cohen, J. Huang, T. Robak, P. Hillmen

Fachzeitschrift
BLOOD

Kurzfassung